Why generic drugs can skip costly clinical trials
Why pay to invent the wheel twice? When producing a generic counterpart, manufacturers legally skip the massively expensive multi-year clinical trials. They only have to prove 'bioequivalence'—meaning their cheap copycat molecule acts virtually identical in systemic circulation compared to the heavily researched original.

Keep exploring facts in this topic.
Health →




